Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-METOPROLOL | 50MG | TABLET | Resolved | 2024-04-05 | 2024-04-26 | 224595 |
| APO-METOPROLOL | 50MG | TABLET | Resolved | 2025-05-15 | 2025-06-27 | 257415 |
| APO-METOPROLOL (TYPE L) | 100MG | TABLET | Resolved | 2025-08-21 | 2025-08-29 | 265820 |
| APO-METOPROLOL (TYPE L) | 50MG | TABLET | Resolved | 2024-11-07 | 2024-12-06 | 242205 |
| APO-METOPROLOL (TYPE L) | 100MG | TABLET | Resolved | 2025-05-01 | 2025-07-04 | 256316 |
| APO-METOPROLOL (TYPE L) | 100MG | TABLET | Resolved | 2024-05-03 | 2024-06-28 | 227068 |
| APO-METOPROLOL (TYPE L) | 100MG | TABLET | Resolved | 2020-09-22 | 2020-11-23 | 124789 |
| APO-METOPROLOL (TYPE L) | 100MG | TABLET | Resolved | 2025-04-10 | 2025-07-04 | 254844 |
| APO-METOPROLOL (TYPE L) | 100MG | TABLET | Resolved | 2020-12-28 | 2021-02-09 | 130716 |
| APO-METOPROLOL (TYPE L) | 100MG | TABLET | Resolved | 2024-06-06 | 2024-07-05 | 229770 |
| APO-METOPROLOL (TYPE L) | 100MG | TABLET | Resolved | 2024-10-04 | 2024-12-06 | 239352 |
| APO-METOPROLOL (TYPE L) | 50MG | TABLET | Resolved | 2025-02-20 | 2025-05-16 | 250935 |
| APO-METOPROLOL (TYPE L) | 100MG | TABLET | Resolved | 2024-10-18 | 2024-12-06 | 240642 |
| APO-METOPROLOL (TYPE L) TAB 100MG | 100MG | TABLET | Resolved | 2020-04-29 | 2020-08-05 | 113394 |
| APO-METRONIDAZOLE | 500MG | CAPSULE | Resolved | 2022-04-08 | 2022-05-14 | 158364 |
| APO-METRONIDAZOLE | 500MG | CAPSULE | Resolved | 2025-01-23 | 2025-03-07 | 248483 |
| APO-METRONIDAZOLE | 500MG | CAPSULE | Resolved | 2024-06-06 | 2024-10-25 | 229749 |
| APO-METRONIDAZOLE TABLETS | 250MG | TABLET | Resolved | 2024-10-04 | 2024-11-01 | 239361 |
| APO-METRONIDAZOLE TABLETS | 250MG | TABLET | Resolved | 2025-01-30 | 2025-02-14 | 249080 |
| APO-METRONIDAZOLE TABLETS | 250MG | TABLET | Resolved | 2025-09-18 | 2025-10-16 | 267476 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 119950 |
| APO-QUININE | 300MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60714 |
| APO-QUININE | 200MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60711 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-09-08 | 2018-10-05 | 60717 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-02-23 | 2019-09-12 | 40805 |
| APO-RAMIPRIL | 1.25MG | CAPSULE | Discontinued | 2018-09-08 | 2019-03-29 | 60720 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
| APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60729 |
| APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
| APO-RILUZOLE | 50MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60744 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60747 |
| APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64965 |
| APO-RISPERIDONE | 1MG | SOLUTION | To be discontinued | 2019-03-11 | 2019-03-11 | 78260 |